HomeSBMFF • OTCMKTS
add
Sino Biopharmaceutical Ltd
Nakaraang pagsara
$0.49
Sakop ng taon
$0.31 - $0.49
Market cap
73.39B HKD
Average na Volume
456.00
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 6.50B | — |
Gastos sa pagpapatakbo | 4.40B | — |
Net na kita | 241.34M | — |
Net profit margin | 3.72 | — |
Kita sa bawat share | — | — |
EBITDA | 1.08B | — |
Aktuwal na % ng binabayarang buwis | -7.28% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 14.60B | 3.39% |
Kabuuang asset | 65.41B | 2.84% |
Kabuuang sagutin | 22.63B | -11.01% |
Kabuuang equity | 42.77B | — |
Natitirang share | 17.92B | — |
Presyo para makapag-book | 0.28 | — |
Return on assets | 3.25% | — |
Return on capital | 4.04% | — |
Cash Flow
Net change in cash
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 241.34M | — |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020.
The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
CEO
Itinatag
2000
Website
Mga Empleyado
24,379
